2020201920182017201620152014 March 30, 2017 Summary ToggleSpero Therapeutics Receives $6.8 Million Award from CARB-X to Combat Antibiotic-Resistant Bacteria March 28, 2017 Summary ToggleSpero Therapeutics to Present at 16th Annual Needham Healthcare Conference March 08, 2017 Summary ToggleSpero Therapeutics Secures $51.7 Million in Oversubscribed Series C Financing February 28, 2017 Summary ToggleSpero Therapeutics to Present at Upcoming March Conferences January 31, 2017 Summary ToggleSpero Therapeutics Acquires Next Generation Antibacterial Candidates from Pro Bono Bio for Treatment of Multidrug-Resistant, Gram-Negative Infections December 19, 2016 Summary ToggleSpero Therapeutics Initiates First Clinical Study of Lead Potentiator Candidate for the Treatment of Multidrug Resistant Gram-Negative Infections November 10, 2016 Summary ToggleSpero Therapeutics to Present at Two Upcoming November Conferences October 18, 2016 Summary ToggleSpero Therapeutics Announces $1.65 Million Award from Department of Defense to Develop Novel Combination Therapy for Multidrug-Resistant, Gram-Negative Pathogens September 06, 2016 Summary ToggleSpero Therapeutics to Participate in Citi’s 11th Annual Biotech Conference September 06, 2016 Summary ToggleSpero Therapeutics Joins ENABLE (European Gram-negative Antibacterial Engine) Project to Combat Antibiotic-Resistant Bacteria Pagination First page First Previous page Previous … Page 7 Current page 8 Page 9 Page 10 Next page Next Last page Last
